Peri-Transplant Radiotherapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing ASCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Peri-transplant radiotherapy in refractory or relapsed Hodgkin lymphoma patients undergoing autologous stem cell transplant: long term results of a retrospective study of the Fondazione Italiana Linfomi (FIL)
Int. J. Radiat. Oncol. Biol. Phys 2023 Feb 21;[EPub Ahead of Print], M Levis, BA Campbell, F Matrone, L Grapulin, AD Russo, M Buglione, II De Cumis, G Simontacchi, P Ciammella, A Magli, G Pascale, S Meregalli, M MacManus, G Fanetti, F De Felice, G Furfaro, G Ciccone, U RicardiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.